Rodney Joe, MD
Gastroenterology · Olympia, WANPI 1558342501
Payments from drug & device makers
Across 20 payments — averaging $54.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fujifilm Healthcare Americas Corporation$790
- AbbVie$85
- E.r. Squibb & Sons, L.L.C.$82
- Olympus America Inc.$79
- Johnson & Johnson$25
- Neuronetics, Inc.$16
- plus $23 from 2 others
What the payments were for
- Food & beverage$30928%
- Gifts$52448%
- Other$26624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fujifilm Healthcare Americas Corporation | 9 | $790 |
| AbbVie | 2 | $85 |
| E.r. Squibb & Sons, L.L.C. | 1 | $82 |
| Olympus America Inc. | 4 | $79 |
| Johnson & Johnson | 1 | $25 |
| Neuronetics, Inc. | 1 | $16 |
| Intercept Pharmaceuticals, Inc. | 1 | $12 |
| Gilead | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ESD - Core Endoscopy$280
- FUJIFILM$202
How this compares
$1,098 in reported general payments places this provider in the 55th percentile of 447 gastroenterology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XeljanzTofacitinib Citrate | 12 | $67,964 |
| Sucralfate | 31 | $2,260 |
| Omeprazole | 207 | $2,248 |
| Azathioprine | 15 | $1,595 |
| Pantoprazole Sodium | 74 | $1,443 |
| Famotidine | 50 | $1,098 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 54 | $911 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $872 |
| Esomeprazole Magnesium | 33 | $778 |
| Morphine Sulfate | 23 | $736 |
| Sulfasalazine | 14 | $654 |
| Dicyclomine Hcl | 26 | $555 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 24 | $546 |
| Ondansetron OdtOndansetron | 13 | $230 |
| Promethazine Hcl | 13 | $81 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Olympia
- Kris KowdleySeattle$5.9M
- Michael ChioreanIssaquah$3.9M
- Scott LeeSeattle$3.7M
- Timothy ZismanSeattle$3.3M
- William HoldermanTacoma$3.1M
- James LordSeattle$1.9M
- Charles LandisSeattle$1.7M
- Robert WohlmanBellevue$1.5M
- Asma SiddiqueSeattle$1.3M
- Harold PreiksaitisSpokane$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.